相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer
Jian Ming et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer
Joji Kitayama et al.
BMC CANCER (2011)
Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy
N. Ceze et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Editorial [Hot Topic: Targeting the Microenvironment in Hematological Malignancies: How to Condition both Stromal and Effector Cells to Overcome Cancer Spreading(Guest Editors: Maria Raffaella Zocchi and Alessandro Poggi)]
Maria Raffaella Zocchi et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy
Yu Ri Kim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Immune profile of elderly patients admitted in a geriatric short care unit
E. Cretel et al.
REVUE DE MEDECINE INTERNE (2011)
Neutrophils in the activation and regulation of innate and adaptive immunity
Alberto Mantovani et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Bone invading NSCLC cells produce IL-7: mice model and human histologic data
Ilaria Roato et al.
BMC CANCER (2010)
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study
Oscar Arrieta et al.
BMC CANCER (2010)
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
A. Dufresne et al.
BRITISH JOURNAL OF CANCER (2010)
Study of lymphocyte subpopulations in bone marrow in a model of protein-energy malnutrition
Ricardo Ambrosio Foci et al.
NUTRITION (2010)
Pharmacogenomics and -genetics in colorectal cancer
Alexandra Pohl et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Isabelle Ray-Coquard et al.
CANCER RESEARCH (2009)
Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: A mechanism of lymphangiogenesis in lung cancer
Jian Ming et al.
EUROPEAN JOURNAL OF CANCER (2009)
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma
Lara Cattaruzza et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8+ T-cell lymphopenia
A. J. Hart et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Michel P. Coleman et al.
LANCET ONCOLOGY (2008)
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: A National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study
George P. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7
Angela Malaspina et al.
BLOOD (2007)
IL-7 Up-Regulates TNF-α-Dependent Osteoclastogenesis in Patients Affected by Solid Tumor
Ilaria Roato et al.
PLOS ONE (2006)
A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer
S. Popat et al.
ANNALS OF ONCOLOGY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation:: Influence of tumor site, type of mutation, and adjuvant treatment
A Russo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis
PL Coletta et al.
BLOOD (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer:: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study
CJ Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Capecitabine - A review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer
AJ Wagstaff et al.
DRUGS (2003)
分享论文
